Skip to main content

Day: September 24, 2025

Global rise in extreme weather drives US$35m ABB investment in new UK factory

ABB’s new manufacturing and R&D facility in Nottingham, UKABB Installation Products opens a £27m state-of-the-art manufacturing and R&D facility for earthing and lightning protection solutions.ABB expands R&D and production of its Furse® earthing and lightning solutionsABB’s new Nottingham facility will produce millions of meters of copper products annually and distribute to 60 countries across Europe, the Middle East, APAC and the US.Nottingham, United Kingdom, Sept. 24, 2025 (GLOBE NEWSWIRE) —State-of-the-art £27m manufacturing and R&D facility for earthing and lightning protection solutions opens in Nottingham, UK   Investment will help meet growing demand for electrical protection that safeguards buildings, data centers, renewable energy systems and critical infrastructure...

Continue reading

Apollo Expands Wealth Platform with Three Evergreen ELTIFs, Unlocking Broader Access to Private Markets

Apollo European Private Credit ELTIF, Apollo Global Diversified Credit ELTIF and Apollo Global Private Markets ELTIF Receive Regulatory Authorization Launch Provides Investors in EMEA as well as Asia and LatAm with Greater Access to Institutional-Quality Private Markets Strategies Under the ELTIF 2.0 Regime LONDON, Sept. 24, 2025 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that it has received regulatory authorization to launch three new evergreen, semi-liquid European Long-Term Investment Funds (“ELTIFs” or the “Funds”):Apollo European Private Credit ELTIF (“AEPC ELTIF”), an evergreen, semi-liquid fund that will seek to provide investors with attractive income from newly originated, primarily first-lien, senior secured direct lending to large-cap and upper middle-market European companies Apollo Global Diversified...

Continue reading

Announcement of Sampo plc’s results and Annual General Meeting in 2026

Sampo plc, stock exchange release, 24 September 2025 at 10:15 am EEST Announcement of Sampo plc’s results and Annual General Meeting in 2026 Sampo plc will publish a Financial Statement Release for 2025 on 5 February 2026. Sampo will report its results on following days during 2026: – 6 May 2026: Interim Statement for the period January–March 2026 – 12 August 2026: Half-Year Financial Report for the period January–June 2026 – 4 November 2026: Interim Statement for the period January–September 2026 The financial results will be published at approximately 8:30 am Finnish time (6:30 am UK time). The Financial Statements and the Board of Directors’ Report, including Corporate Governance Statement and Sustainability Statement, and the Remuneration Report for Governing Bodies for 2025 will be published at www.sampo.com/year2025...

Continue reading

CARBIOS presents its 2025 half-year results and confirms its objective to build a PET biorecycling plant, with a revised timeline.

   CARBIOS has reduced its operating expenses and has a strong cash position of €72 million as of June 30, 2025, providing a cash horizon of more than 12 months The Longlaville plant construction project is now supported by:Major progress with public financers ADEME and the Regional Council Clear interest from private investors, conditional upon the pre-sale of a significant portion of the future plant’s capacity, which has not yet been achieved Recent regulatory developments that enhance the competitiveness of CARBIOS’ technologyIn this context, the resumption of the Longlaville plant construction project is expected before the end of 2025, subject to securing the necessary funding. The plant would then be commissioned in the second half of 2027.Clermont-Ferrand (France), September 24, 2025 (08 :45 CEST). CARBIOS (Euronext Growth Paris:...

Continue reading

S&P Global Ratings affirms Akropolis Group’s BB+ credit rating with stable outlook following planned Galio Group acquisition

International credit rating agency S&P Global Ratings, having assessed Akropolis Group’s plans to acquire the residential and commercial real estate development and management company Galio Group, has affirmed the BB+ rating with stable outlook assigned to the company for the fourth consecutive year.  “The confirmation of our rating by an international agency is significant for our business operations, partners, and investors. Significantly, this latest review was carried out after evaluating the impact of the planned strategic acquisition on the company’s financial stability and growth prospects. This demonstrates that the decision to acquire Galio Group will contribute to further value creation and strengthen Akropolis Group’s position in the Baltic real estate market,” said Gabrielė Sapon, CEO of Akropolis Group.  After reviewing...

Continue reading

Sampo plc’s share buybacks 23 September 2025

Sampo plc, stock exchange release, 24 September 2025 at 8:30 am EEST Sampo plc’s share buybacks 23 September 2025                                                  On 23 September 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  4,126 9.62 AQEU    147,419 9.62 CEUX  39,739 9.63 TQEX  206,790 9.62 XHELTOTAL 398,074 9.62  * rounded to two decimals                      On 6 August 2025, Sampo announced a share buyback programme of up to a maximum of EUR 200 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation...

Continue reading

Press release – AFL’s 2025 half-yearly results: strong growth in results that supports its development

AFL’s 2025 half-yearly results:Strong growth in results that supports its development AFL Group announced a strong improvement in its results as of 30 June 2025:Net banking income rose by 43% to 15.4 million euros and by 27% after inclusion of the AT1 interest expenses, compared to the first half of 2024 Gross operating income doubled to 6.3 million euros and grew by 58% after inclusion of the AT1 interest expenses, compared to the first half of 2024 Loan production for the half-year increased by 18% to 728 million euros compared to the first half of 2024 2 capital increases brought in 87 new local authority shareholders, bringing the total number of local authorities shareholders to 1,131 Liquidity stands at 2.1 billion euros, enabling AFL to meet all its operational requirements for 10 months Capitalisation is solid, with a bank...

Continue reading

Himax WiseEye Ultralow Power AI Sensing Technology Adopted in Acer’s New Ultra-Thin and Lightweight AI PC

Enabling Smart Human Detection and Interactive Awareness to Elevate AI in Endpoint Devices TAINAN, Taiwan, Sept. 24, 2025 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced that its WiseEye™ ultralow power AI sensing solution has been successfully adopted in Acer’s Swift Edge 14 AI series, a slim and lightweight AI notebook that has already entered mass production. Himax’s WiseEye solution equips Acer’s AI notebook with advanced human detection and interactive awareness features, including Human Presence Detection (HPD) and health reminder alerts such as for prolonged use or close viewing distance as well as posture correction notifications. Additionally, it introduces a multi-screen...

Continue reading

Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation

Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovationThe fund will remain focused on Sanofi’s key areas of immunology, rare diseases, neurology, and vaccines, backing earlier-stage innovation and emerging opportunities that support the company’s long-term strategy Sanofi Ventures drives innovation through leading and participating in private financing rounds for pioneering healthcare companiesParis, September 24, 2025. Sanofi Ventures has announced an additional $625 million multi-year capital commitment from Sanofi, increasing its total assets under management to over $1.4 billion. This new commitment to the evergreen venture fund builds on more than a decade of investing in innovative biotech and digital health companies that align with Sanofi’s long-term...

Continue reading

Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan

BEDFORD, Mass. and CHICAGO and TOKYO, Sept. 24, 2025 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc.  (NASDAQ: LNTH) and GE HealthCare (NASDAQ: GEHC) today announced an exclusive licensing agreement for GE HealthCare to develop, manufacture, and commercialize Lantheus’ piflufolastat F18 (PYLARIFY® in U.S. market) in Japan for prostate cancer diagnostics and companion diagnostic use. PYLARIFY is used for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer. The agreement includes the transfer of regulatory dossiers, manufacturing competencies and technical support to enable GE HealthCare to drive clinical development in Japan, towards potential regulatory submissions and commercial launch. GE HealthCare will draw on its extensive manufacturing network and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.